Literature DB >> 31422063

Metabolic health in the Middle East and north Africa.

Fereidoun Azizi1, Farzad Hadaegh2, Farhad Hosseinpanah3, Parvin Mirmiran4, Atieh Amouzegar1, Hengameh Abdi1, Golaleh Asghari5, Donna Parizadeh2, Seyed Ali Montazeri3, Mojtaba Lotfaliany6, Farzin Takyar1, Davood Khalili7.   

Abstract

The Middle East and north Africa are home to different populations with widely varying cultures, histories, and socioeconomic settings. Hence, their health status, health management, and access to appropriate health care differ accordingly. In this Review, we examine data on the historical and prospective status of metabolic diseases in this region including obesity, diabetes, hypertension, dyslipidaemia, and non-alcoholic fatty liver disease. Women in the Middle East and north Africa have the highest risk of metabolic diseases of all women globally, whereas men rank second of all men in this respect. Metabolic risk factors are responsible for more than 300 deaths per 100 000 individuals in this region, compared with a global mean of fewer than 250. Physical inactivity, especially in women, and an unhealthy diet (ie, low consumption of whole grains, nuts, and seafoods) stand out. More than one in every three women are obese in most countries of the region. Prevention programmes have not fully been achieved in most of these countries and the projected future is not optimistic. Comprehensive surveillance and monitoring of metabolic diseases, robust multisectoral systems that support primordial and primary preventions, continuous education of health-care providers, as well as collaboration between countries for joint projects in this region are urgently needed to overcome the paucity of data and to improve the metabolic health status of inhabitants in the Middle East and north Africa.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31422063     DOI: 10.1016/S2213-8587(19)30179-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN: 2213-8587            Impact factor:   32.069


  31 in total

1.  Changes in ideal cardiovascular health among Iranian adolescents: 2007-2008 to 2015-2017.

Authors:  Golaleh Asghari; Parvin Mirmiran; Alireza Rezaeemanesh; Maryam Mahdavi; Fereiodoun Azizi; Farzad Hadaegh
Journal:  BMC Pediatr       Date:  2022-07-26       Impact factor: 2.567

2.  The Burden of Osteoarthritis in the Middle East and North Africa Region From 1990 to 2019.

Authors:  Ali Shamekh; Mahasti Alizadeh; Seyed Aria Nejadghaderi; Mark J M Sullman; Jay S Kaufman; Gary S Collins; Ali-Asghar Kolahi; Saeid Safiri
Journal:  Front Med (Lausanne)       Date:  2022-06-23

3.  Simple risk score to screen for prediabetes: A cross-sectional study from the Qatar Biobank cohort.

Authors:  Mostafa Abbas; Raghvendra Mall; Khaoula Errafii; Abdelkader Lattab; Ehsan Ullah; Halima Bensmail; Abdelilah Arredouani
Journal:  J Diabetes Investig       Date:  2020-12-01       Impact factor: 4.232

4.  External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population.

Authors:  Samaneh Asgari; Fatemeh Moosaie; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2020-07-02       Impact factor: 5.531

5.  Knowledge, Attitude, and Practice Regarding Cardiovascular Diseases in Adults Attending Health Care Centers in Tehran, Iran.

Authors:  Fatemeh Koohi; Davood Khalili
Journal:  Int J Endocrinol Metab       Date:  2020-10-01

Review 6.  Iranian Endocrine Society Guidelines for Screening, Diagnosis, and Management of Gestational Diabetes Mellitus.

Authors:  Majid Valizadeh; Farhad Hosseinpanah; Fahimeh Ramezani Tehrani; Hengameh Abdi; Ladan Mehran; Farzad Hadaegh; Atieh Amouzegar; Farzaneh Sarvghadi; Fereidoun Azizi
Journal:  Int J Endocrinol Metab       Date:  2020-12-23

7.  Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007-2016.

Authors:  Hamid Malekzadeh; Mojtaba Lotfaliany; Afshin Ostovar; Farzad Hadaegh; Fereidoun Azizi; Moein Yoosefi; Farshad Farzadfar; Davood Khalili
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

8.  Anti-Atherosclerotic Properties of Wild Rice in Low-Density Lipoprotein Receptor Knockout Mice: The Gut Microbiome, Cytokines, and Metabolomics Study.

Authors:  Mohammed H Moghadasian; Ramandeep Kaur; Kayla Kostal; Akhila A Joshi; Mahboubeh Molaei; Khuong Le; Gabor Fischer; Francesca Bonomini; Gaia Favero; Rita Rezzani; Branden S J Gregorchuk; Vanessa Leung-Shing; Michelle Wuzinski; Andy I Seo; Denice C Bay
Journal:  Nutrients       Date:  2019-11-28       Impact factor: 5.717

9.  Comparison of the Modification of Diet in Renal Disease Study and Chronic Kidney Disease Epidemiology Collaboration Equations for Detection of Cardiovascular Risk: Tehran Lipid and Glucose Study.

Authors:  Pouria Mousapour; Maryam Barzin; Majid Valizadeh; Maryam Mahdavi; Fereidoun Azizi; Farhad Hosseinpanah
Journal:  Int J Endocrinol Metab       Date:  2020-11-22

10.  Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study.

Authors:  Seyyed Saeed Moazzeni; Reyhane Hizomi Arani; Niloofar Deravi; Mitra Hasheminia; Davood Khalili; Fereidoun Azizi; Farzad Hadaegh
Journal:  Cardiovasc Diabetol       Date:  2021-07-12       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.